Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 4th Quarter - Termination (No Activity)

PHARMATHENE, INC

via ROSEMONT GROUP

4th Quarter (Oct 1 - Dec 31) · 2016Posted Jan 25, 2017Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: PHARMATHENE, INC
Description: Manufacturing and research
Location: Maryland · United States of America

Registrant

Firm: ROSEMONT GROUP
Description: government affairs consulting
Location: WASHINGTON, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

PHARMATHENE, INC — Lobbying — Receipts Report